Literature DB >> 20592069

Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms.

John R Teijaro1, David Verhoeven, Carly A Page, Damian Turner, Donna L Farber.   

Abstract

Memory CD4 T cells specific for influenza virus are generated from natural infection and vaccination, persist long-term, and recognize determinants in seasonal and pandemic influenza virus strains. However, the protective potential of these long-lived influenza virus-specific memory CD4 T cells is not clear, including whether CD4 T-cell helper or effector functions are important in secondary antiviral responses. Here we demonstrate that memory CD4 T cells specific for H1N1 influenza virus directed protective responses to influenza virus challenge through intrinsic effector mechanisms, resulting in enhanced viral clearance, recovery from sublethal infection, and full protection from lethal challenge. Mice with influenza virus hemagglutinin (HA)-specific memory CD4 T cells or polyclonal influenza virus-specific memory CD4 T cells exhibited protection from influenza virus challenge that occurred in the presence of CD8-depleting antibodies in B-cell-deficient mice and when CD4 T cells were transferred into lymphocyte-deficient RAG2(-/-) mice. Moreover, the presence of memory CD4 T cells mobilized enhanced T-cell recruitment and immune responses in the lung. Neutralization of gamma interferon (IFN-gamma) production in vivo abrogated memory CD4 T-cell-mediated protection from influenza virus challenge by HA-specific memory T cells and heterosubtypic protection by polyclonal memory CD4 T cells. Our results indicate that memory CD4 T cells can direct enhanced protection from influenza virus infection through mobilization of immune effectors in the lung, independent of their helper functions. These findings have important implications for the generation of universal influenza vaccines by promoting long-lived protective CD4 T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592069      PMCID: PMC2937635          DOI: 10.1128/JVI.01069-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.

Authors:  Modesta P Ndejembi; John R Teijaro; Deepa S Patke; Adam W Bingaman; Meena R Chandok; Agnes Azimzadeh; Steven G Nadler; Donna L Farber
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

Authors:  Xiao-Song He; Tyson H Holmes; Caiqiu Zhang; Kutubuddin Mahmood; George W Kemble; David B Lewis; Cornelia L Dekker; Harry B Greenberg; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Novel phenotypes and migratory properties distinguish memory CD4 T cell subsets in lymphoid and lung tissue.

Authors:  Adam W Bingaman; Deepa S Patke; Vaishali R Mane; Mojgan Ahmadzadeh; Modesta Ndejembi; Stephen T Bartlett; Donna L Farber
Journal:  Eur J Immunol       Date:  2005-11       Impact factor: 5.532

4.  Uneven distribution of MHC class II epitopes within the influenza virus.

Authors:  Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland
Journal:  Vaccine       Date:  2005-08-15       Impact factor: 3.641

5.  Divergent generation of heterogeneous memory CD4 T cells.

Authors:  Vaishali R Moulton; Nicholas D Bushar; David B Leeser; Deepa S Patke; Donna L Farber
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

Review 6.  Influenza and the challenge for immunology.

Authors:  Peter C Doherty; Stephen J Turner; Richard G Webby; Paul G Thomas
Journal:  Nat Immunol       Date:  2006-05       Impact factor: 25.606

7.  Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

Authors:  Georgia Deliyannis; Katherine Kedzierska; Yuk Fai Lau; Weiguang Zeng; Stephen J Turner; David C Jackson; Lorena E Brown
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

8.  Mechanism of protective immunity against influenza virus infection in mice without antibodies.

Authors:  S L Epstein; C Y Lo; J A Misplon; J R Bennink
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 9.  Role of the B-cell response in recovery of mice from primary influenza virus infection.

Authors:  W Gerhard; K Mozdzanowska; M Furchner; G Washko; K Maiese
Journal:  Immunol Rev       Date:  1997-10       Impact factor: 12.988

10.  CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.

Authors:  Deborah M Brown; Allison M Dilzer; Dana L Meents; Susan L Swain
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

View more
  103 in total

1.  Age-related changes in durability and function of vaccine-elicited influenza-specific CD4(+) T-cell responses.

Authors:  Yolanda D Mahnke; Areej Saqr; Staci Hazenfeld; Rebecca C Brady; Mario Roederer; Ramu A Subbramanian
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

2.  The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

3.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

4.  Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.

Authors:  Vinay Rambal; Karin Müller; Chantip Dang-Heine; Arne Sattler; Mikalai Dziubianau; Benjamin Weist; Si-Hong Luu; Alexandra Stoyanova; Peter Nickel; Andreas Thiel; Avidan Neumann; Brunhilde Schweiger; Petra Reinke; Nina Babel
Journal:  Med Microbiol Immunol       Date:  2013-09-22       Impact factor: 3.402

5.  Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.

Authors:  Moon Cheol Kang; Dong-Hoon Choi; Young Woo Choi; Seong Jeong Park; Hong Namkoong; Ki Seok Park; So-Shin Ahn; Charles D Surh; Sun-Woo Yoon; Doo-Jin Kim; Jung-ah Choi; Yunji Park; Young Chul Sung; Seung-Woo Lee
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

6.  Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans.

Authors:  Lyndsey M Muehling; Ronald B Turner; Kenneth B Brown; Paul W Wright; James T Patrie; Sampo J Lahtinen; Markus J Lehtinen; William W Kwok; Judith A Woodfolk
Journal:  J Infect Dis       Date:  2018-01-17       Impact factor: 5.226

7.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis.

Authors:  Victoria K Baxter; Diane E Griffin
Journal:  J Gen Virol       Date:  2016-09-22       Impact factor: 3.891

9.  Differential mucosal IL-10-induced immunoregulation of innate immune responses occurs in influenza infected infants/toddlers and adults.

Authors:  David Verhoeven; Sheldon Perry
Journal:  Immunol Cell Biol       Date:  2016-09-15       Impact factor: 5.126

10.  A Chlamydia-Specific TCR-Transgenic Mouse Demonstrates Th1 Polyfunctionality with Enhanced Effector Function.

Authors:  Taylor B Poston; Yanyan Qu; Jenna Girardi; Catherine M O'Connell; Lauren C Frazer; Ali N Russell; McKensie Wall; Uma M Nagarajan; Toni Darville
Journal:  J Immunol       Date:  2017-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.